Bacterin will showcase its new spinal product line, the 3Demin product family, at the North American Spine Society meeting in San Francisco, from Nov. 12 to 14.
The company's executives will also attend the NASS meeting and will be available to answer questions about Bacterin's spine product portfolio including OsteoSponge, OsteoSelect DBM Putty, OsteoWrap, OsteoSTX and the new 3Demin product line.
Bacterin focuses on developing, manufacturing and marketing biologic products to domestic and international markets.
More articles on devices:
Stryker hip implant settlement to exceed $1.4B—10 key facts
Orthopedic device market stock report—5 company updates
Alphatec Spine 3Q revenue up 2%: 10 key concepts